为与微量营养素计划相关的术语制定标准化的共识词典
Lwin Mar Hlaing1,2, Megan W Bourassa1, Kenneth H Brown1,3
1The Micronutrient Forum, Washington, DC, United States of America.
PloS one
|August 30, 2024
概括
一个新的词典协调了微量营养素计划的术语,特别是大规模的食品强化 (LSFF). 该资源有助于各种利益相关者进行清晰的沟通和明智的决策,以减少微量营养素缺乏.
科学领域:
- 公共卫生 营养 公共卫生 营养
- 食品科学 食品科学 食品科学
- 卫生政策 卫生政策
背景情况:
- 微量营养素计划中不一致的术语,特别是大规模的食品强化 (LSFF),阻碍了不同利益相关者之间的有效沟通.
- 利益相关者包括公共和私营部门,捐助机构,食品行业和学术机构,每个都有独特的术语.
研究的目的:
- 建立基于共识的微量营养素计划的关键术语词典,包括LSFF.
- 创建定义的中央存储库,以促进所有相关方之间的清晰沟通和协调.
主要方法:
- 汇编了联合国机构,实施支持机构,网站和科学文献的条款,以关键干预和计划周期为指导.
- 应用了修改后的Delphi方法来协调多个现有定义的术语的定义.
- 与140多名微量营养素专家进行专家审查和在线调查,以就定义达成共识.
主要成果:
- 开发了一个包含217个术语的词典,包括19个法律和83个微量营养素术语.
- 通过专家协议,在定义上达成共识,要求超过75%的协议被认为是最终的.
- 该词典可以在网上作为一个活着的文件进行持续更新.
结论:
- 开发的词典为关键的微量营养素计划术语提供了协调的定义.
- 它将加强沟通,计划评估和知情决策,以应对微量营养素缺乏.
- 词典是利益相关者比较计划绩效和推动进步的重要工具.
更多相关视频
09:13Hydroponics: A Versatile System to Study Nutrient Allocation and Plant Responses to Nutrient Availability and Exposure to Toxic Elements
Published on: July 13, 2016
31.8K
05:35Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
736
相关概念视频
Key Elements for Plant Nutrition
18.7K
Like all living organisms, plants require organic and inorganic nutrients to survive, reproduce, grow and maintain homeostasis. To identify nutrients that are essential for plant functioning, researchers have leveraged a technique called hydroponics. In hydroponic culture systems, plants are grown—without soil—in water-based solutions containing nutrients. At least 17 nutrients have been identified as essential elements required by plants. Plants acquire these elements from the...
18.7K
Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
Dose-Response Relationship: Overview
3.1K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.1K
Preclinical Development: Overview
4.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.3K
Health Literacy
4.0K
Health literacy is an individual's or a community's capacity to comprehend, receive, read, and use relevant healthcare information and services. The World Health Organization (WHO, 2018) defines health literacy as the cognitive and social skills that determine the ability of individuals to gain access to, understand, and use information in ways that promote and maintain good health. As a result, the WHO helps individuals manage long-term health concerns, participate in preventative...
4.0K
Dose-Response Relationship: Potency and Efficacy
4.3K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.3K
